GlassScriptPhysician profile
Michael S Boedefeld
NPI 1043299548
$13,175.51
in general payments reported to CMS, 2019-2025
56 companies · $1,850 in 2025
The $1,850 reported for 2025 was more than what 81% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,401 · 2020: $1,117 · 2021: $1,131 · 2022: $1,979 · 2023: $1,758 · 2024: $1,941 · 2025: $1,850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,488 · Travel and Lodging: $1,015 · Entertainment: $44.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,488.13 |
| Travel and Lodging | $1,015.31 |
| Entertainment | $44.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $2,019.01 | 2021-2025 | Ha Minuteman G3-R |
| Vertiflex, INC. | $1,959.62 | 2019 | |
| Boston Scientific Corporation | $1,232.34 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Relievant Medsystems, INC. | $1,084.00 | 2023 | Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,060.23 | 2019-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $558.02 | 2019-2025 | Belbuca, Xtampza |
| Foundation Fusion Solutions, LLC | $512.86 | 2024-2025 | |
| Abbvie INC. | $442.48 | 2021-2024 | Botox, Qulipta |
| Biotronik Nro, INC. | $385.08 | 2023-2025 | Prospera, Biotronik |
| Abbott Laboratories | $364.31 | 2020-2025 | Eterna, Proclaim |
| Pfizer INC. | $302.01 | 2019-2020 | |
| Nalu Medical, INC. | $301.14 | 2021-2025 | Nalu Neurostimulation System |
| Medtronic, INC. | $291.23 | 2021-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $274.30 | 2019-2023 | Senza |
| Arbor Pharmaceuticals, INC. | $224.45 | 2019-2022 |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Boedefeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.